Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1834.55%
operating margin TTM
-1955.35%
revenue TTM
24.30 Million
revenue per share TTM
0.55$
valuation ratios | |
|---|---|
| pe ratio | -0.87 |
| peg ratio | 0.08 |
| price to book ratio | 0.60 |
| price to sales ratio | 16.19 |
| enterprise value multiple | -2.46 |
| price fair value | 0.60 |
profitability ratios | |
|---|---|
| gross profit margin | 59.3% |
| operating profit margin | -1955.35% |
| pretax profit margin | -1834.55% |
| net profit margin | -1834.55% |
| return on assets | -44.36% |
| return on equity | -58.83% |
| return on capital employed | -51.9% |
liquidity ratio | |
|---|---|
| current ratio | 10.10 |
| quick ratio | 10.10 |
| cash ratio | 9.85 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 50.02 |
| days of payables outstanding | 328.45 |
| cash conversion cycle | -278.43 |
| receivables turnover | 7.30 |
| payables turnover | 1.11 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.26 |
| debt equity ratio | 0.41 |
| long term debt to capitalization | 0.22 |
| total debt to capitalization | 0.29 |
| interest coverage | -14.31 |
| cash flow to debt ratio | -1.26 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.07 |
| cash per share | 2.81 |
| operating cash flow per share | -1.06 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -1.26 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -141.40 |
Frequently Asked Questions
When was the last time Werewolf Therapeutics, Inc. (NASDAQ:HOWL) reported earnings?
Werewolf Therapeutics, Inc. (HOWL) published its most recent earnings results on 07-11-2024.
What is Werewolf Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Werewolf Therapeutics, Inc. (NASDAQ:HOWL)'s trailing twelve months ROE is -58.83%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Werewolf Therapeutics, Inc. (HOWL) currently has a ROA of -44.36%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did HOWL's net profit margin stand at?
HOWL reported a profit margin of -1834.55% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is HOWL's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 10.10 in the most recent quarter. The quick ratio stood at 10.10, with a Debt/Eq ratio of 0.41.